Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Jui Ho

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Research Square|October 16, 2023
Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunctionCorina Amor, Inés Fernández-Maestre, Saria Chowdhury, et al.
Cell|September 3, 2021
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerMarcus Ruscetti, John P Morris, Riccardo Mezzadra, et al.
Cell|April 3, 2020
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerMarcus Ruscetti, John P Morris, Riccardo Mezzadra, et al.
Nature|February 4, 2021
A gene-environment-induced epigenetic program initiates tumorigenesisDirena Alonso-Curbelo, Yu-Jui Ho, Cassandra Burdziak, et al.
Nature Aging|January 24, 2024
Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunctionCorina Amor, Inés Fernández-Maestre, Saria Chowdhury, et al.
Nature|March 29, 2023
STING inhibits the reactivation of dormant metastasis in lung adenocarcinomaJing Hu, Francisco J Sánchez-Rivera, Zhenghan Wang, et al.
Science (New York, N.Y.)|December 22, 2018
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combinationMarcus Ruscetti, Josef Leibold, Matthew J Bott, et al.
Nature Cancer|May 4, 2023
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillanceLoretah Chibaya, Katherine C Murphy, Kelly D DeMarco, et al.
Blood|January 10, 2025
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemiaScott E Millman, Almudena Chaves-Perez, Sudha Janaki-Raman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2022
A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targetsXiang Li, Chun-Hao Huang, Francisco J Sánchez-Rivera, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Research Square|October 16, 2023
Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunctionCorina Amor, Inés Fernández-Maestre, Saria Chowdhury, et al.
Cell|September 3, 2021
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerMarcus Ruscetti, John P Morris, Riccardo Mezzadra, et al.
Cell|April 3, 2020
Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas CancerMarcus Ruscetti, John P Morris, Riccardo Mezzadra, et al.
Nature|February 4, 2021
A gene-environment-induced epigenetic program initiates tumorigenesisDirena Alonso-Curbelo, Yu-Jui Ho, Cassandra Burdziak, et al.
Nature Aging|January 24, 2024
Prophylactic and long-lasting efficacy of senolytic CAR T cells against age-related metabolic dysfunctionCorina Amor, Inés Fernández-Maestre, Saria Chowdhury, et al.
Nature|March 29, 2023
STING inhibits the reactivation of dormant metastasis in lung adenocarcinomaJing Hu, Francisco J Sánchez-Rivera, Zhenghan Wang, et al.
Science (New York, N.Y.)|December 22, 2018
NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combinationMarcus Ruscetti, Josef Leibold, Matthew J Bott, et al.
Nature Cancer|May 4, 2023
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillanceLoretah Chibaya, Katherine C Murphy, Kelly D DeMarco, et al.
Blood|January 10, 2025
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemiaScott E Millman, Almudena Chaves-Perez, Sudha Janaki-Raman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 20, 2022
A preclinical platform for assessing antitumor effects and systemic toxicities of cancer drug targetsXiang Li, Chun-Hao Huang, Francisco J Sánchez-Rivera, et al.
Pageof 7